Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil with or without flurbiprofen axetil for postoperative cognitive outcomes in elderly major surgery patients
ChiCTR-IPR-17010845Phase 4Completed
- Sponsor
- Department of Anesthesiology, Cancer Hospital of Harbin Medical University
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in post-operative cognitive decline (POCD) comparing Flurbiprofen axetil + sufentanil with Sufentanil (2 arms). Primary endpoint: Score of postoperative cognitive dysfunction. Started Mar 2017; status: completed.
02
Drugs
sufentanilflurbiprofen axetil
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-IPR-17010845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010845.